Forwarded from PDFology (Basem Medhat)
Forwarded from PDFology (Basem Medhat)
Forwarded from PDFology (Basem Medhat)
تلخيصات طبية
1~4.pdf
تفريغات د طارق المقطري فارما
#Pharmacy
#Tafreghat
#غزة 🇵🇸
🚨 اعلانات التلجرام تظهر بشكل إجباري ولا يمكن إلغائها فضلاً عمل ريبورت لأي إعلان قد يظهر به شبهة حرمانية 🚨
#Pharmacy
#Tafreghat
#غزة 🇵🇸
🚨 اعلانات التلجرام تظهر بشكل إجباري ولا يمكن إلغائها فضلاً عمل ريبورت لأي إعلان قد يظهر به شبهة حرمانية 🚨
Forwarded from PDFology (Basem Medhat)
تلخيصات طبية
Photo
💊 علاج للضغط كل ست شهور!
📋 Zilebesiran is an exciting new drug currently under development for the treatment of hypertension (high blood pressure). Here's a breakdown of the key details:
🔍 What it is:
* Zilebesiran is an investigational RNA interference (RNAi) therapeutic. RNAi is a technology that can silence specific genes.
* In this case, zilebesiran targets the gene for angiotensinogen, a protein involved in regulating blood pressure. By reducing angiotensinogen levels, zilebesiran aims to lower blood pressure.
🛠️ How it works:
* Zilebesiran is delivered subcutaneously, meaning it's injected under the skin.
* It utilizes a specific technology called ESC+ GalNAc-conjugate, which allows for infrequent dosing (potentially twice-yearly or quarterly).
* Early studies suggest a single dose can effectively reduce blood pressure for up to six months.
📊 What the research shows:
* Phase 2 clinical trials have shown promise. A single dose of zilebesiran significantly lowered both systolic and diastolic blood pressure for up to 24 weeks in people with mild-to-moderate hypertension.
* The reduction in blood pressure was consistent throughout the day and night, which is important for optimal blood pressure control.
* The study also found zilebesiran to be well-tolerated, with only mild injection site reactions reported.
⚠️ Important things to note:
* Zilebesiran is still under development, and further studies are needed to confirm its efficacy and safety in larger populations.
* It's not yet available for prescription.
* If you have high blood pressure, it's crucial to consult with your doctor about the best treatment options for you.
🌐 Reference ➡️ Pubmed
#PDFology
#رفح_تحت_القصف 🇵🇸
🚨 اعلانات التلجرام تظهر بشكل إجباري ولا يمكن إلغائها فضلاً عمل ريبورت لأي إعلان قد يظهر به شبهة حرمانية 🚨
📋 Zilebesiran is an exciting new drug currently under development for the treatment of hypertension (high blood pressure). Here's a breakdown of the key details:
🔍 What it is:
* Zilebesiran is an investigational RNA interference (RNAi) therapeutic. RNAi is a technology that can silence specific genes.
* In this case, zilebesiran targets the gene for angiotensinogen, a protein involved in regulating blood pressure. By reducing angiotensinogen levels, zilebesiran aims to lower blood pressure.
🛠️ How it works:
* Zilebesiran is delivered subcutaneously, meaning it's injected under the skin.
* It utilizes a specific technology called ESC+ GalNAc-conjugate, which allows for infrequent dosing (potentially twice-yearly or quarterly).
* Early studies suggest a single dose can effectively reduce blood pressure for up to six months.
📊 What the research shows:
* Phase 2 clinical trials have shown promise. A single dose of zilebesiran significantly lowered both systolic and diastolic blood pressure for up to 24 weeks in people with mild-to-moderate hypertension.
* The reduction in blood pressure was consistent throughout the day and night, which is important for optimal blood pressure control.
* The study also found zilebesiran to be well-tolerated, with only mild injection site reactions reported.
⚠️ Important things to note:
* Zilebesiran is still under development, and further studies are needed to confirm its efficacy and safety in larger populations.
* It's not yet available for prescription.
* If you have high blood pressure, it's crucial to consult with your doctor about the best treatment options for you.
🌐 Reference ➡️ Pubmed
#PDFology
#رفح_تحت_القصف 🇵🇸
🚨 اعلانات التلجرام تظهر بشكل إجباري ولا يمكن إلغائها فضلاً عمل ريبورت لأي إعلان قد يظهر به شبهة حرمانية 🚨
Forwarded from PDFology (Basem Medhat)
Antidepressant drugs.pdf
12.3 MB
تفريغ د عبد المتعال فودة CNS
Lecture: 11
Antidepressant drugs
By Dr Maymounah
"من إستفاد فلا ينسى الشهيد أبو آية بدعوة صادقة"
#Pharmacy
#Neurology
#Tafreghat
#رفح_تحت_القصف 🇵🇸
Lecture: 11
Antidepressant drugs
By Dr Maymounah
"من إستفاد فلا ينسى الشهيد أبو آية بدعوة صادقة"
#Pharmacy
#Neurology
#Tafreghat
#رفح_تحت_القصف 🇵🇸
Forwarded from PDFology (Basem Medhat)
سورة الكهف.pdf
3.7 MB
قال أبي سعيد الخدري رضي الله عنه: قال رسول الله صلى الله عليه وسلم: من قرأ سورة الكهف في يوم الجمعة، أضاء له من النور ما بين الجمعتين. رواه الحاكم والبيهقي وصححه الألباني.
﴿ إِنَّ اللَّهَ وَمَلَائِكَتَهُ يُصَلُّونَ عَلَى النَّبِيِّ ۚ يَا أَيُّهَا الَّذِينَ آمَنُوا صَلُّوا عَلَيْهِ وَسَلِّمُوا تَسْلِيمًا﴾
[ الأحزاب: 56]
🚨 اعلانات التلجرام تظهر بشكل إجباري ولا يمكن إلغائها فضلاً عمل ريبورت لأي إعلان قد يظهر به شبهة حرمانية 🚨
﴿ إِنَّ اللَّهَ وَمَلَائِكَتَهُ يُصَلُّونَ عَلَى النَّبِيِّ ۚ يَا أَيُّهَا الَّذِينَ آمَنُوا صَلُّوا عَلَيْهِ وَسَلِّمُوا تَسْلِيمًا﴾
[ الأحزاب: 56]
🚨 اعلانات التلجرام تظهر بشكل إجباري ولا يمكن إلغائها فضلاً عمل ريبورت لأي إعلان قد يظهر به شبهة حرمانية 🚨
Forwarded from نافع | Nafe3
لأن فيه ناس بتتشتت من كثرة كتيبات الدعاء، هعنمل جلسة (اجمع قلبك) كجلسة مركزة للدعاء إن شاء الله بتمام الساعة 5 بتوقيت مصر..
ترقبوها..
ترقبوها..